Bertrand et al. reported that CD70 was markedly upregulated in both germinal center B-cell-like and activated B-cell-like DLBCL compared to normal tissue, with elevated CD70 expression associated with shorter overall survival in both subtypes [15]. The gene discussed is CD70; the disease is diffuse large B-cell lymphoma.